IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 28 filers reported holding IMMUCELL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $72,716 | -16.2% | 14,230 | 0.0% | 0.01% | -22.2% |
| Q4 2022 | $86,803 | -28.3% | 14,230 | -12.3% | 0.01% | -35.7% |
| Q3 2022 | $121,000 | -14.2% | 16,230 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $141,000 | -10.2% | 16,230 | 0.0% | 0.02% | +6.7% |
| Q1 2022 | $157,000 | +17.2% | 16,230 | -3.0% | 0.02% | +15.4% |
| Q4 2021 | $134,000 | -20.2% | 16,730 | -5.6% | 0.01% | -27.8% |
| Q3 2021 | $168,000 | 0.0% | 17,730 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $168,000 | +20.0% | 17,730 | +21.9% | 0.02% | +12.5% |
| Q1 2021 | $140,000 | +97.2% | 14,550 | +21.2% | 0.02% | +77.8% |
| Q4 2020 | $71,000 | +9.2% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $65,000 | +12.1% | 12,000 | -3.1% | 0.01% | 0.0% |
| Q2 2020 | $58,000 | +262.5% | 12,390 | +313.0% | 0.01% | +200.0% |
| Q3 2019 | $16,000 | -15.8% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $19,000 | 0.0% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $19,000 | -9.5% | 3,000 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $21,000 | -19.2% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $26,000 | +30.0% | 3,000 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $20,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |